{
    "symbol": "XAIR",
    "quarter": 3,
    "year": 2023,
    "date": "2023-02-09 20:29:10",
    "content": " $3 million of the increase was due to the planned structural investments in Beyond Cancer, with the remaining $1 million attributed -- attributable to continued investments in people and systems necessary to support the commercial launch of LungFit PH in the U.S. Other income and expense for the fiscal quarter ended December 31, 2022, was a $0.2 million gain, compared with a $0.5 million loss for the fiscal quarter ended December 31, 2021. For the fiscal quarter ended December 31, 2022, the company had a GAAP net loss of $13.8 million, of which $12.7 million or $0.43 per share was attributable to the shareholders of Beyond Air, Inc. compared with a net loss of $7.7 million or $0.29 per share for the fiscal quarter ended December 31, 2021."
}